MAS
UTHR icon

Meeder Advisory Services’s United Therapeutics UTHR Stock Holding History

Meeder Advisory Services’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$392K Buy
661
+26
+4% +$12.9K 0.02% 452
2025
Q4 		$310K Buy
635
+50
+9% +$23.3K 0.01% 515
2025
Q3 		$245K Buy
+585
New +$197K 0.01% 540
2025
Q1 		– Sell
-656
Closed -$231K – 594
2024
Q4 		$231K Buy
656
+28
+4% +$10.3K 0.01% 505
2024
Q3 		$225K Buy
+628
New +$212K 0.01% 500

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Meeder Advisory Services's UTHR Position: Q1 2026 in Review

Meeder Advisory Services increased its United Therapeutics (UTHR) stake by 4.1% in Q1 2026, buying an estimated $12.9K and bringing the position to 661 shares worth $392K. The position accounts for 0.02% of the portfolio, ranked #452.

Meeder Advisory Services first reported a position in UTHR in Q3 2024 and has held it in 5 quarters since. 850 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • Meeder Advisory Services held 661 shares of United Therapeutics worth $392K as of Q1 2026.
  • Meeder Advisory Services bought 26 United Therapeutics shares in Q1 2026, an estimated $12.9K.
  • United Therapeutics made up 0.02% of Meeder Advisory Services's portfolio in Q1 2026, its #452 holding.
  • Meeder Advisory Services first reported a position in United Therapeutics in Q3 2024 and has held it in 5 quarters since.
  • 850 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Meeder Advisory Services's 13F filing for Q1 2026, filed 7 May 2026.